I am working on Global Brand Evaluation (MS Word) survey consists of 31 name candidates, which are being evaluated for a pharmaceutical product (protein therapy for NMIBC (Nonmuscle invasive bladder cancer) that tethers a tumor-targeting antibody fragment to a protein cytotoxic payload to form a single protein molecule designed to selectively & kill cancer cells while minimizing toxicity to healthy cells & to activate the body’s innate immune response system).